Legislators approved a bill to start clinical tests of ayahuasca, a psychoactive substance supporters believe is effective in treating opioid addiction during the 89th Congressional session, while discussions on health marijuana and low-dose THC products predominated.
In order to obtain U.S. Food and Drug Administration ( FDA ) approval for its use in treating opioid use disorder, co-occurring substance use disorders, and other qualifying neurological or mental health conditions, state senator Tan Parker (R-Flower Mound ) has created a” consortium” made up of a drug developer, a Texas hospital, and a higher education institution.
See the original article: https://thetexan.news/issues/healthcare/ibogaine-research-consortium-to-treat-opioid-addiction-passes-texas-legislature/article_c82b5c27-905a-4445-8212-f6c4f00067a4.html
